MARASCO, VINCENZO
MARASCO, VINCENZO
Universita' degli Studi di MILANO
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
2024 S. Viviani, A. Vanazzi, S. Frassoni, C. Rusconi, A. Rossi, A. Romano, C. Patti, C. Schiavotto, R. Sorasio, V. Marasco, L. Lissandrini, D. Rapezzi, D. Gottardi, F. Cocito, A. Mulè, S. Leotta, G. Gini, M. Sorio, E. Derenzini, A. Rambaldi, V. Bagnardi, C. Tarella
Nonrestrictive diet does not increase infections during post-HSCT neutropenia: data from a multicenter randomized trial
2023 F. Stella, V. Marasco, G.V. Levati, A. Guidetti, A. De Filippo, M. Pennisi, C. Vismara, R. Miceli, S. Ljevar, C. Tecchio, N. Mordini, G. Gobbi, L. Saracino, P. Corradini
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study
2022 V. Marasco, A. Piciocchi, A. Candoni, L. Pagano, A. Guidetti, P. Musto, R. Bruna, M. Bocchia, A. Visentin, M. Turrini, A. Tucci, S. Pilerci, L. Fianchi, M. Salvini, S. Galimberti, E. Coviello, C. Selleri, M. Luppi, E. Crea, P. Fazi, F. Passamonti, P. Corradini
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study
2022 P. Corradini, C. Agrati, G. Apolone, A. Mantovani, D. Giannarelli, V. Marasco, V. Bordoni, A. Sacchi, G. Matusali, C. Salvarani, P.L. Zinzani, R. Mantegazza, F. Tagliavini, M.T. Lupo-Stanghellini, F. Ciceri, S. Damian, A. Uccelli, D. Fenoglio, N. Silvestris, F. Baldanti, G. Piaggio, G. Ciliberto, A. Morrone, F. Locatelli, V. Sinno, M. Rescigno, M. Costantini
SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma
2020 C. Rusconi, G. Cassanello, A. Guidetti, C. Oltolini, V. Marasco, L. Morabito, M. Della Porta, R. Lanocita, G. Papagni, C. Carniti, P. Corradini